Reuters logo
BRIEF-Arvinas announces research collaboration and license agreement with Pfizer Inc
January 4, 2018 / 5:17 AM / 13 days ago

BRIEF-Arvinas announces research collaboration and license agreement with Pfizer Inc

Jan 4 (Reuters) - Arvinas LLC:

* ARVINAS ANNOUNCES RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH PFIZER INC. FOR THE DISCOVERY AND DEVELOPMENT OF PROTEIN DEGRADATION DRUG CANDIDATES

* ANNOUNCED A RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH PFIZER INC​

* ARVINAS SAYS MAY RECEIVE UP TO $830 MILLION IN UPFRONT AND POTENTIAL DEVELOPMENT AND COMMERCIALIZATION MILESTONE PAYMENTS UPON ACHIEVEMENT OF SPECIFIED MILESTONES​

* ‍CO MAY BE ENTITLED TO RECEIVE TIERED ROYALTIES BASED ON GLOBAL PRODUCT SALES ON ANY PRODUCTS THAT MAY RESULT FROM COLLABORATION​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below